These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 1535593)
1. Pharmacokinetics and dialysability of isradipine in chronic haemodialysis patients. Schönholzer K; Marone C Eur J Clin Pharmacol; 1992; 42(2):231-3. PubMed ID: 1535593 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of amlodipine in hypertensive patients undergoing haemodialysis. Kungys G; Naujoks H; Wanner C Eur J Clin Pharmacol; 2003 Aug; 59(4):291-5. PubMed ID: 12845505 [TBL] [Abstract][Full Text] [Related]
3. Effect of diltiazem on the pharmacokinetics of MPC-1304, a new calcium channel blocker. Ohashi K; Sudo T; Sakamoto K; Tateishi T; Fujimura A; Kumagai Y; Shiga T; Ebihara A Int J Clin Pharmacol Ther Toxicol; 1992 Aug; 30(8):271-4. PubMed ID: 1526689 [TBL] [Abstract][Full Text] [Related]
4. Enantioselective determination of lercanidipine in human plasma for pharmacokinetic studies by normal-phase liquid chromatography-tandem mass spectrometry. Jabor VA; Coelho EB; Ifa DR; Bonato PS; dos Santos NA; Lanchote VL J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Nov; 796(2):429-37. PubMed ID: 14581082 [TBL] [Abstract][Full Text] [Related]
5. The pharmacokinetics of oral isradipine in normal volunteers. Clifton GD; Blouin RA; Dilea C; Schran HF; Hassell AE; Gonasun LM; Foster TS J Clin Pharmacol; 1988 Jan; 28(1):36-42. PubMed ID: 2965165 [TBL] [Abstract][Full Text] [Related]
6. A study of plasma disposition kinetics of lacidipine after single oral ascending doses. Squassante L; Caveggion E; Braggio S; Pellegatti M; Baroldi P J Cardiovasc Pharmacol; 1994; 23 Suppl 5():S94-7. PubMed ID: 7609516 [TBL] [Abstract][Full Text] [Related]
7. Initial experience with isradipine for the treatment of hypertension in children. Strauser LM; Groshong T; Tobias JD South Med J; 2000 Mar; 93(3):287-93. PubMed ID: 10728516 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of nisoldipine in renal dysfunction. Boelaert J; Valcke Y; Dammekens H; De Vriese G; Ahr G; Schurgers M; Daneels R; Bogaert MG Eur J Clin Pharmacol; 1988; 34(2):207-9. PubMed ID: 3383992 [TBL] [Abstract][Full Text] [Related]
9. The pharmacokinetics of ziprasidone in subjects with normal and impaired renal function. Aweeka F; Jayesekara D; Horton M; Swan S; Lambrecht L; Wilner KD; Sherwood J; Anziano RJ; Smolarek TA; Turncliff RZ Br J Clin Pharmacol; 2000; 49 Suppl 1(Suppl 1):27S-33S. PubMed ID: 10771451 [TBL] [Abstract][Full Text] [Related]
10. Isradipine dynamics and pharmacokinetics in the isolated rabbit heart. Mellemkjaer S; Bang L; Nielsen-Kudsk F Pharmacol Toxicol; 1992 May; 70(5 Pt 1):366-72. PubMed ID: 1535129 [TBL] [Abstract][Full Text] [Related]
11. The pharmokinetics of isradipine in hypertensive subjects. Shenfield GM; Boutagy J; Stokes GS; Rumble F; Dunagan F Eur J Clin Pharmacol; 1990; 38(2):209-11. PubMed ID: 2140098 [TBL] [Abstract][Full Text] [Related]
12. Comparative binding of two closely related dihydropyridines (isradipine and darodipine) to serum proteins and erythrocytes. Pinquier JL; Urien S; Lemaire M; Chaumet-Riffaud P; Tillement JP Pharmacology; 1988; 36(5):305-12. PubMed ID: 2457222 [TBL] [Abstract][Full Text] [Related]
13. Absorption, plasma concentration, and excretion after single administration of 14C-(+-)-3-(benzylmethylamino)-2,2-dimethylpropyl methyl 4-(2-fluoro-5- nitrophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate hydrochloride in rats and dogs. Matsunaga T; Tanabe H; Mochizuki T; Okabe K; Arizono H; Taneda M; Sato H; Ishii S; Sato J; Kiyoki M Arzneimittelforschung; 1992 Apr; 42(4):519-25. PubMed ID: 1642676 [TBL] [Abstract][Full Text] [Related]
14. [Pharmacokinetic and pharmacodynamic effects of isradipine in patients with arterial hypertension]. Svetyĭ LI; Alekhin SN Eksp Klin Farmakol; 2002; 65(5):35-8. PubMed ID: 12596512 [TBL] [Abstract][Full Text] [Related]
15. Clinical hypotension with co-prescription of macrolide antibiotics and calcium-channel blockers in haemodialysis patients: a retrospective chart review. Hiremath S; Ruzicka M; Nagaraju SP; McCormick BB Drug Saf; 2013 Oct; 36(10):989-93. PubMed ID: 23873482 [TBL] [Abstract][Full Text] [Related]
16. Single dose pharmacokinetics of manidipine in hepatic impaired patients and healthy controls. Deroubaix X; Lins RL; Lens S; Allemon A; Jeanbaptiste B; Poli G; Acerbi D; Stockis A; Ventura P Int J Clin Pharmacol Ther; 1998 Jul; 36(7):386-91. PubMed ID: 9707354 [TBL] [Abstract][Full Text] [Related]
17. Radioligand and functional estimates of the interaction of the 1,4-dihydropyridines, isradipine and lacidipine, with calcium channels in smooth muscle. Salomone S; Godfraind T Br J Pharmacol; 1993 May; 109(1):100-6. PubMed ID: 8495233 [TBL] [Abstract][Full Text] [Related]
18. Lack of effect of the calcium antagonist isradipine on cyclosporine pharmacokinetics in renal transplant patients. Endresen L; Bergan S; Holdaas H; Pran T; Sinding-Larsen B; Berg KJ Ther Drug Monit; 1991 Nov; 13(6):490-5. PubMed ID: 1837629 [TBL] [Abstract][Full Text] [Related]
19. Isradipine--another calcium-channel blocker for the treatment of hypertension and angina. Lopez LM; Santiago TM Ann Pharmacother; 1992 Jun; 26(6):789-99. PubMed ID: 1535246 [TBL] [Abstract][Full Text] [Related]
20. In vivo specific binding characteristics and pharmacokinetics of a 1,4-dihydropyridine calcium channel antagonist in the senescent mouse brain. Uchida S; Yamada S; Deguchi Y; Yamamoto M; Kimura R Pharm Res; 2000 Jul; 17(7):844-50. PubMed ID: 10990204 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]